Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling.
about
Cancer drug resistance: redox resetting renders a waySelenocysteine derivative overcomes TRAIL resistance in melanoma cells: evidence for ROS-dependent synergism and signaling crosstalk.Chlorogenic acid enhances the effects of 5-fluorouracil in human hepatocellular carcinoma cells through the inhibition of extracellular signal-regulated kinases.Piperlongumine selectively kills hepatocellular carcinoma cells and preferentially inhibits their invasion via ROS-ER-MAPKs-CHOP.Strategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand complexSalinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation(77)Se chemical shift tensor of L-selenocystine: experimental NMR measurements and quantum chemical investigations of structural effects.Therapeutic effect of TMZ-POH on human nasopharyngeal carcinoma depends on reactive oxygen species accumulation.Cyanidin suppresses amyloid beta-induced neurotoxicity by inhibiting reactive oxygen species-mediated DNA damage and apoptosis in PC12 cells.SW43-DOX ± loading onto drug-eluting bead, a potential new targeted drug delivery platform for systemic and locoregional cancer treatment - An in vitro evaluationRegulation of multidrug resistance by microRNAs in anti-cancer therapyMiR-155 and its functional variant rs767649 contribute to the susceptibility and survival of hepatocellular carcinoma.Pulsed Electromagnetic Field Stimulation Promotes Anti-cell Proliferative Activity in Doxorubicin-treated Mouse Osteosarcoma Cells.Reactive oxygen species mediate heat stress-induced apoptosis via ERK dephosphorylation and Bcl-2 ubiquitination in human umbilical vein endothelial cells.Cariporide Enhances the DNA Damage and Apoptosis in Acid-tolerable Malignant Mesothelioma H-2452 CellsInduction of G1 Cell Cycle Arrest in Human Glioma Cells by Salinomycin Through Triggering ROS-Mediated DNA Damage In Vitro and In Vivo.A CD13 inhibitor, ubenimex, synergistically enhances the effects of anticancer drugs in hepatocellular carcinoma.Cytotoxic, apoptotic, and sensitization properties of ent-kaurane-type diterpenoids from Croton tonkinensis Gagnep on human liver cancer HepG2 and Hep3b cell lines.EGF Protects Cells Against Dox-Induced Growth Arrest Through Activating Cyclin D1 Expression.Rational design of selenadiazole derivatives to antagonize hyperglycemia-induced drug resistance in cancer cells.Selenocysteine induces apoptosis in human glioma cells: evidence for TrxR1-targeted inhibition and signaling crosstalk.Antiangiogenic properties of caudatin in vitro and in vivo by suppression of VEGF‑VEGFR2‑AKT/FAK signal axis.Caudatin induces caspase-dependent apoptosis in human glioma cells with involvement of mitochondrial dysfunction and reactive oxygen species generation.Oxymatrine synergistically enhances the inhibitory effect of 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo.DSePA Antagonizes High Glucose-Induced Neurotoxicity: Evidences for DNA Damage-Mediated p53 Phosphorylation and MAPKs and AKT Pathways.Astaxanthin Attenuates Homocysteine-Induced Cardiotoxicity in Vitro and in Vivo by Inhibiting Mitochondrial Dysfunction and Oxidative Damage.Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System.Selenocysteine antagonizes oxygen glucose deprivation-induced damage to hippocampal neurons
P2860
Q26750753-84D0DCCD-34EE-4F6D-BBCE-502937052C96Q34365708-72AC3BA2-8490-44A2-8D9E-1194744302ECQ35558263-393CF37B-E7D8-4844-9587-A8368ECA3914Q35742552-BCE2E56E-27CC-4887-B3C8-C005BBABC9A8Q35824678-A09384CD-46BE-4CCE-9305-25F0EABD430BQ35833001-0218AC64-3D80-473D-8EA3-EF6073064BDEQ36090068-9A993835-38EB-4E3A-926B-D1A838D08978Q36738925-959F26A2-8FD1-4FB6-A2BE-FE7B00E418E0Q36996618-182F74AB-BEA3-4805-B696-C53D04A53566Q37150075-E6B9EB65-7946-45CD-BE46-BBE01A2E634EQ37587311-EE319C0F-99C0-4A9A-8FAE-500514021D31Q37645018-041BDDD2-2DD4-4E70-9CD7-842EEC68D1BFQ37705293-544396AE-58A1-4FC7-BFA7-3C6C621B933DQ37706519-E199A4F7-480A-4978-AA65-5F108E86997FQ38611440-1B6703C5-8B0B-48A5-AF6B-CBEFD45E1724Q38725332-276CB579-2834-4BB2-82D4-539B299965E3Q38775002-66D7A477-22DD-40BB-A034-68F72FC022EFQ38808287-C71F47A6-7F55-4145-88E5-95C4ADC17CD5Q38903957-11411443-B184-406B-B113-0777BEAC8DE7Q38914068-762AC2A5-EE70-4ADC-8149-691F3C6DAF33Q41124658-2871223E-7D50-4638-8809-A96D9BB48B2AQ46291408-9D80E3ED-C121-442E-874F-5783C5FC31B9Q46547610-B7D5FFEE-F138-4CCA-A9F3-422BBA899E4AQ46621540-A8430D20-0AC6-414F-BA57-523AB98FD4A6Q46691816-3E58B0A7-256C-49CD-8BCC-418A6AEDEFE2Q47443896-8BC071BC-9CEA-4A99-A959-19BD6434B890Q52647762-D14AD8A1-84FA-4444-93FD-0385A0F0A524Q58805398-4378E4B8-18BF-4747-BAD1-EDBEF1DC0E70
P2860
Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Strategy to enhance the therap ...... es the ROS-mediated signaling.
@ast
Strategy to enhance the therap ...... es the ROS-mediated signaling.
@en
type
label
Strategy to enhance the therap ...... es the ROS-mediated signaling.
@ast
Strategy to enhance the therap ...... es the ROS-mediated signaling.
@en
prefLabel
Strategy to enhance the therap ...... es the ROS-mediated signaling.
@ast
Strategy to enhance the therap ...... es the ROS-mediated signaling.
@en
P2093
P2860
P356
P1433
P1476
Strategy to enhance the therap ...... es the ROS-mediated signaling.
@en
P2093
Cundong Fan
Tianfeng Chen
Wenjie Zheng
Xiaoling Li
Xiaoyan Fu
Yum-Shing Wong
P2860
P304
P356
10.18632/ONCOTARGET.1854
P407
P577
2014-05-01T00:00:00Z